Related Experiment Video
Updated: May 21, 2026

Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
Voltage-dependent K+ channels as oncotargets in malignant gliomas
Large epidemiological studies are needed to explore the benefits of imipramine and citalopram for malignant glioma patients. Recent studies show digoxin benefits prostate cancer patients, suggesting similar drug repurposing potential for glioma treatments.
Area of Science:
- Oncology
- Neurology
- Pharmacology
Background:
- Depression is a common comorbidity in glioma patients.
- Imipramine and citalopram are frequently prescribed antidepressants.
- Digoxin, a Na+/K+ ATPase inhibitor, has shown benefits in prostate cancer patients.
Discussion:
- Investigating the efficacy of imipramine and citalopram in glioma patients is warranted.
- Epidemiological studies can reveal the therapeutic potential of repurposed drugs.
- The Na+/K+ ATPase pathway may represent a therapeutic target in cancer.
Key Insights:
- Antidepressants like imipramine and citalopram may offer benefits beyond depression in glioma patients.
- Drug repurposing holds promise for novel cancer therapies.
- Further research into digoxin's mechanism in prostate cancer could inform glioma treatment.
Outlook:
- Large-scale epidemiological studies are crucial to validate these findings.
- Exploring the role of Na+/K+ ATPase inhibitors in malignant glioma is a promising research direction.
- This research could lead to improved treatment strategies for glioma patients.
More Related Videos
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
09:33Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Ligand-Gated Ion Channel Receptor: Gating Mechanism
The Role of Ion Channels in Neuronal Computation
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential.